Precigen (PGEN)
(Delayed Data from NSDQ)
$3.12 USD
-0.07 (-2.19%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $3.10 -0.02 (-0.64%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Precigen, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PGEN 3.12 -0.07(-2.19%)
Will PGEN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for PGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PGEN
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
Other News for PGEN
PGEN falls 2.19% on October 10, leaving the technical picture intact
PGEN forms NR7 on October 9
Is PGEN positioned for a breakdown? Fell Below 50 Day Moving Average shows up after sliding 2.72%
PGEN Crossed Above 50 Day Moving Average on October 7
PGEN Fell Below 50 Day Moving Average on October 6